Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)

NCT06502249 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Ain Shams University